These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 30003321)

  • 1. Interactions among myeloid regulatory cells in cancer.
    Umansky V; Adema GJ; Baran J; Brandau S; Van Ginderachter JA; Hu X; Jablonska J; Mojsilovic S; Papadaki HA; Pico de Coaña Y; Santegoets KCM; Santibanez JF; Serre K; Si Y; Sieminska I; Velegraki M; Fridlender ZG
    Cancer Immunol Immunother; 2019 Apr; 68(4):645-660. PubMed ID: 30003321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of myeloid regulatory cells (MRCs) in maintaining tissue homeostasis and promoting tolerance in autoimmunity, inflammatory disease and transplantation.
    Amodio G; Cichy J; Conde P; Matteoli G; Moreau A; Ochando J; Oral BH; Pekarova M; Ryan EJ; Roth J; Sohrabi Y; Cuturi MC; Gregori S
    Cancer Immunol Immunother; 2019 Apr; 68(4):661-672. PubMed ID: 30357490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity.
    Veglia F; Sanseviero E; Gabrilovich DI
    Nat Rev Immunol; 2021 Aug; 21(8):485-498. PubMed ID: 33526920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Notch Signaling in Myeloid Cells as a Regulator of Tumor Immune Responses.
    Hossain F; Majumder S; Ucar DA; Rodriguez PC; Golde TE; Minter LM; Osborne BA; Miele L
    Front Immunol; 2018; 9():1288. PubMed ID: 29915603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relevance of Interferon Regulatory Factor-8 Expression in Myeloid-Tumor Interactions.
    Abrams SI; Netherby CS; Twum DY; Messmer MN
    J Interferon Cytokine Res; 2016 Jul; 36(7):442-53. PubMed ID: 27379866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasticity of myeloid-derived suppressor cells in cancer.
    Tcyganov E; Mastio J; Chen E; Gabrilovich DI
    Curr Opin Immunol; 2018 Apr; 51():76-82. PubMed ID: 29547768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tuning the Tumor Myeloid Microenvironment to Fight Cancer.
    Jahchan NS; Mujal AM; Pollack JL; Binnewies M; Sriram V; Reyno L; Krummel MF
    Front Immunol; 2019; 10():1611. PubMed ID: 31402908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reciprocal relationship between myeloid-derived suppressor cells and T cells.
    Nagaraj S; Youn JI; Gabrilovich DI
    J Immunol; 2013 Jul; 191(1):17-23. PubMed ID: 23794702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Editorial: NK-Myeloid Cell Interactions in the Tumor Microenvironment: Implications for Cancer Immunotherapy.
    Wennerberg E; Lundqvist A; Mao Y; Mougiakakos D
    Front Immunol; 2021; 12():718844. PubMed ID: 34276709
    [No Abstract]   [Full Text] [Related]  

  • 10. Expression of TAM-R in Human Immune Cells and Unique Regulatory Function of MerTK in IL-10 Production by Tolerogenic DC.
    Giroud P; Renaudineau S; Gudefin L; Calcei A; Menguy T; Rozan C; Mizrahi J; Caux C; Duong V; Valladeau-Guilemond J
    Front Immunol; 2020; 11():564133. PubMed ID: 33101282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allies or Enemies-The Multifaceted Role of Myeloid Cells in the Tumor Microenvironment.
    Haas L; Obenauf AC
    Front Immunol; 2019; 10():2746. PubMed ID: 31849950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diamonds in the Rough: Harnessing Tumor-Associated Myeloid Cells for Cancer Therapy.
    Clappaert EJ; Murgaski A; Van Damme H; Kiss M; Laoui D
    Front Immunol; 2018; 9():2250. PubMed ID: 30349530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decidualization Process Induces Maternal Monocytes to Tolerogenic IL-10-Producing Dendritic Cells (DC-10).
    Gori S; Soczewski E; Fernández L; Grasso E; Gallino L; Merech F; Colado A; Borge M; Pérez Leirós C; Salamone G; Ramhorst R
    Front Immunol; 2020; 11():1571. PubMed ID: 32973738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The kinship of neutrophils and granulocytic myeloid-derived suppressor cells in cancer: cousins, siblings or twins?
    Brandau S; Moses K; Lang S
    Semin Cancer Biol; 2013 Jun; 23(3):171-82. PubMed ID: 23459190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-talk between myeloid-derived suppressor cells (MDSC), macrophages, and dendritic cells enhances tumor-induced immune suppression.
    Ostrand-Rosenberg S; Sinha P; Beury DW; Clements VK
    Semin Cancer Biol; 2012 Aug; 22(4):275-81. PubMed ID: 22313874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Navigating tumor angiogenesis: therapeutic perspectives and myeloid cell regulation mechanism.
    Yang F; Lee G; Fan Y
    Angiogenesis; 2024 Aug; 27(3):333-349. PubMed ID: 38580870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. microRNAs Shape Myeloid Cell-Mediated Resistance to Cancer Immunotherapy.
    Daveri E; Vergani E; Shahaj E; Bergamaschi L; La Magra S; Dosi M; Castelli C; Rodolfo M; Rivoltini L; Vallacchi V; Huber V
    Front Immunol; 2020; 11():1214. PubMed ID: 32793185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of immune suppression by myeloid-derived suppressor cells: the role of interleukin-10 as a key immunoregulatory cytokine.
    Yaseen MM; Abuharfeil NM; Darmani H; Daoud A
    Open Biol; 2020 Sep; 10(9):200111. PubMed ID: 32931721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myeloid-Derived Suppressor Cells.
    Gabrilovich DI
    Cancer Immunol Res; 2017 Jan; 5(1):3-8. PubMed ID: 28052991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the origin of myeloid-derived suppressor cells.
    Millrud CR; Bergenfelz C; Leandersson K
    Oncotarget; 2017 Jan; 8(2):3649-3665. PubMed ID: 27690299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.